Erasmus, Elardus, Mason, Shayne, van Reenen, Mari et al. · Metabolomics : Official journal of the Metabolomic Society · 2019 · DOI
This study looked at whether a simple urine test could help measure fatigue severity in ME/CFS patients. Researchers used a specialized scanning technique (NMR) to analyze urine samples from 578 women with chronic fatigue before and after a detoxification challenge, finding that the fatigue group showed different metabolite patterns compared to controls. While the study didn't identify a single reliable biomarker for fatigue, it suggests that fatigue may be connected to how the body processes toxins.
Developing objective biological markers for ME/CFS is critical since the condition currently relies on subjective symptom reporting. This research suggests metabolomics may help objectively characterize fatigue severity and reveals potential links between xenobiotic metabolism and fatigue, potentially pointing toward new therapeutic approaches. Such biomarkers could improve diagnosis and enable more precise patient stratification for research and clinical care.
This study does not prove that abnormal toxin metabolism causes ME/CFS fatigue—it only shows an association. The cross-sectional design prevents determination of whether metabolite changes are a cause or consequence of fatigue. The absence of an identified biomarker means this approach cannot yet be used clinically to diagnose or measure fatigue severity.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →